The pressure to take your drug to market faster is increasing. To achieve a successful journey to the first clinical trial phase in the fastest time possible, we have identified three key elements we are addressing in this eBook.
These elements are all relevant to your biologics discovery to manufacture monoclonal antibodies, recombinant vaccines and mRNA vaccines and therapeutics.
The common step in all three workflows is cloning. Creating an optimised antigen in your upstream development and driving efficiencies is the basis for a successful downstream drug discovery process.
The eBook outlines the benefit of:
Download the interactive eBook to find out how Eppendorf products and solutions can get you to the clinical phase faster.
*To experience this eBook with all features, please use Adobe to view